Achyut Healthcare Ltd
BSE:543499
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
A
|
Achyut Healthcare Ltd
BSE:543499
|
1.3B INR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
118.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.8B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.2B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
54.1B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.9B AUD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Achyut Healthcare Ltd
Glance View
Achyut Healthcare Ltd. engages in the trading of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. The company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The firm is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The firm is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Achyut Healthcare Ltd is -7.1%, which is below its 3-year median of -2.8%.
Over the last 1 years, Achyut Healthcare Ltd’s Operating Margin has decreased from 0.3% to -7.1%. During this period, it reached a low of -7.1% on May 1, 2025 and a high of 0.3% on Mar 2, 2024.